Navigation Links
Two designer drugs hit same lung cancer target, but only one is effective

lleagues wanted to determine whether Erbitux might be another option for NSCLC patients who carry the EGFR mutation. To test this idea, they treated lung cancer cell lines in the laboratory with Iressa and with Erbitux. They reported that both drugs blocked the excess signals in cells with normal EGFR, but only Iressa was significantly effective in those carrying a mutant EGFR.

"It tells us something about the difference in the drugs' ability to cause a regression of the cancer by shutting down the abnormally active growth signal receptor, EGFR," says Janne. "If you want to choose a way of inhibiting the mutant EGFR receptor, you would pull Iressa and Tarceva off the shelf, not Erbitux."

Iressa and Tarceva are known as small-molecule drugs that can be taken orally and block the part of the EGFR molecule that's located within the cell. In NSCLC, patients with the mutation often respond to both drugs, though only Tarceva has helped patients live slightly longer in clinical trials. Erbitux is a monoclonal antibody drug that binds to a portion of the EGFR receptor that extends outside the cell. This difference in action is the apparent explanation for why they performed differently against the mutant EGFR cells.

The scientists also looked at cases of four NSCLC patients with EGFR mutations who had been treated with the two drugs. The scientists' predictions were confirmed: all patients had some tumor shrinkage when they received Iressa, but none of the cancers responded to Erbitux.

Janne says that the experiment told the scientists something new about the biology of the EGFR mutation in NSCLC. "The lesson is, to inhibit the mutant receptor, you need to inhibit the domain of the EGFR molecule that lies within the cell, as opposed to the extracellular domain," Jänne says.


'"/>

Source:Dana-Farber Cancer Institute


Page: 1 2

Related biology news :

1. Mouse with designer liver has enhanced glucose tolerance, insulin response
2. Molecular machine may lead to new drugs to combat human diseases
3. Researchers identify target for cancer drugs
4. MetaChip provides quick, efficient toxicity screening of potential drugs
5. Newly discovered pathway might help in design of cancer drugs
6. UNC launches study of liver injury caused by drugs
7. Findings have implications for tracking disease, drugs at the molecular level
8. Future diabetes drugs may target new protein interaction
9. UCLA study assesses cost-effectiveness of Hepatitis B drugs
10. Sponges as drugs
11. Newest HIV drugs should be used with FUZEON(R)
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Two designer drugs hit same lung cancer target but only one effective

(Date:5/22/2013)... 22, 2013. Plastic additives known as phthalates (pronounced ... They turn up in flooring, plastic cups, beach ... Centers for Disease Control and Preventionthe bodies of ... come under increasing scrutiny. A growing collection of ... leech from packaging and mix with food) may ...
(Date:5/21/2013)... the nation,s land and water resources could likely support ... 25 billion gallons of algae-based fuel a year in ... , The findings come from an in-depth look at ... significant amounts of algae in large, specially built shallow ... issue of Environmental Science and Technology , published ...
(Date:5/21/2013)... Cancers of all types become most deadly when they ... has reached this stage, it becomes very difficult for ... can develop. Now, researchers at the University of Missouri ... target lymphoma tumor cells wherever they may be in ... in the MU College of Veterinary Medicine, says being ...
Breaking Biology News(10 mins):Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4MU researchers develop radioactive nanoparticles that target cancer cells 2
... of radiation based on verified scientific facts will be available ... The official kick-off meeting of the Community project ULICE ... Union is supporting with nearly 10 million euros, was held ... Therapy of the Heidelberg University Hospital. This consortium consists of ...
... the U.S. population is afflicted with an autoimmune ... chronic and require life-long care. Moreover, different autoimmune ... are caused by disruptions in common biological pathways. ... pathways, The Jackson Laboratory has published "Pathways to ...
... at UT Southwestern Medical Center have eliminated non-small cell ... drug called BEZ235 in combination with low-dose radiation. ... Cancer Research , UT Southwestern researchers found that ... of tumor cells with otherwise nontoxic radiation, the drug ...
Cached Biology News:Patients in Europe benefit from new radiation therapy 2Patients in Europe benefit from new radiation therapy 3UT Southwestern researchers use drug-radiation combo to eradicate lung cancer 2
(Date:5/23/2013)... Toronto, Canada (PRWEB) May 23, 2013 ... subjects, it is critical to adhere to principles ... protection (HSP). , Esteemed speaker Dr. Jeremy Lim, ... the audience: , ,     Understand the ... Clinical Practice (GCP) and additional regulations for the ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 ... ancestry tracing for people of African descent, today ... product offering. For people of all races, myDNAmix ... from five distinct populations: Indigenous Americas (Native American), ... India Subcontinent. , Originally launched in ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Watlow®, ... of complete thermal systems, recently introduced its new ... years of experience in designing and manufacturing industrial ... of products to serve diverse customer needs. , ... featured at the beginning of the book. These ...
(Date:5/22/2013)... Oven Industries announces the new 5R1-1400 ... via a PC through the TTL level UART Communication ... inches square can deliver up to 15 AMPS of ... solid state relay. Operator safety is achieved with 1KV ... and sensor input. Specifications: Input Voltage 85 to ...
Breaking Biology Technology:Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 3Watlow Introduces Its New Industrial Heater Catalog 2New AC Temperature Controller Announced by Oven Industries 2
... 3 Albert Liou, Corporate Vice,President and General ... PRXL ), a leading global,biopharmaceutical services provider, will ... Cost and Efficiency Savings in Running Clinical,Trials?" at ... and,Exhibition, to be held November 4 - 7, ...
... Altogen Biosystems (http://www.altogen.com ),announced launch of novel ... facilities for animal testing. Transfection is,one of the ... RNA molecules,into cells and tissues. This technique makes ... a gene or a small interfering RNA (siRNA),into ...
... N.J., Nov. 3 Arno Therapeutics,Inc. (OTC Bulletin Board: ... announced that Dr. Roger G. Berlin,Chief Executive Officer of ... Healthcare Conference on Monday, November 10, 2008 at 2:00 ... York Palace Hotel in New York City. Dr.,Berlin will ...
Cached Biology Technology:PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress 2PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress 3PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress 4Altogen Biosystems Launches New Nanoparticle-based In Vivo Transfection Reagent 2Arno Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference 2
Sheep polyclonal to Melatonin ( Abpromise for all tested applications). Antigen: Melatonin Tg conjugate....
Goat anti-PITPN Class: Antibody Product Group: Miscellaneous Antibody...
COMING SOON: Anti-Mouse CD205 (DEC-205),Clone NLDC-145, mAb...
Anti-MT3-MMP Membrane-Type Metalloproteinase-3; propeptide domain; rabbit host...
Biology Products: